Is Taurolidine-citrate an effective and cost-effective hemodialysis catheter lock solution? A systematic review and cost- effectiveness analysis (Q38889942)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Is Taurolidine-citrate an effective and cost-effective hemodialysis catheter lock solution? A systematic review and cost- effectiveness analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

Is Taurolidine-citrate an effective and cost-effective hemodialysis catheter lock solution? A systematic review and cost- effectiveness analysis (English)

1 reference

Europe PubMed Central

7 September 2017

catheterization

0 references

author name string

Zahra Kavosi

1

1 reference

Europe PubMed Central

7 September 2017

Maryam Sarikhani Khorrami

2

1 reference

Europe PubMed Central

7 September 2017

Khosro Keshavarz

3

1 reference

Europe PubMed Central

7 September 2017

Abdosaleh Jafari

4

1 reference

Europe PubMed Central

7 September 2017

Amir Hashemi Meshkini

5

1 reference

Europe PubMed Central

7 September 2017

Hamid Reza Safaei

6

1 reference

Europe PubMed Central

7 September 2017

Shekoufeh Nikfar

7

1 reference

Europe PubMed Central

7 September 2017

publication date

2 April 2016

1 reference

Europe PubMed Central

7 September 2017

Medical Journal of the Islamic Republic of Iran

1 reference

Europe PubMed Central

7 September 2017

30

1 reference

Europe PubMed Central

7 September 2017

347

1 reference

Europe PubMed Central

7 September 2017

A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4898874

9 September 2017

A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4898874

9 September 2017

The evolving role of taurolidine in cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4898874

9 September 2017

Taurolidine and catheter-related bloodstream infection: a systematic review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4898874

9 September 2017

Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4898874

9 September 2017

Prevention of catheter-related blood stream infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4898874

9 September 2017

Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4898874

9 September 2017

Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4898874

9 September 2017

Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4898874

14 September 2017

Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4898874

17 June 2018

Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4898874

22 August 2018

A new haemodialysis catheter-locking agent reduces infections in haemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4898874

22 August 2018

Catheter-related bloodstream infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/27390716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38889942&oldid=1794073424"